Dr. Will Soliman is the Founder and CEO of the Accreditation Council for Medical Affairs (ACMA), the global leader in life sciences accreditation, certification, and training. A former pharmaceutical executive with leadership roles at Merck, AbbVie, and Gilead, Dr. Soliman has dedicated his career to advancing professional standards across the pharmaceutical industry. He also leads White Mana Capital Partners, a biotech and pharmaceutical-focused hedge fund, and is widely recognized as a pharmaceutical industry futurist. In 2021, he testified before the U.S. Congress on the importance of ethical and professional standards for industry representatives. Frequently featured in major media outlets like Forbes, Fox News, and ABC, Dr. Soliman continues to shape the future of healthcare through innovation, education, and advocacy.